Readying students for careers in industry: A guided inquiry activity to prepare students for success in biotechnology and pharmaceutical industry positions

Readying students for careers in industry: A guided inquiry activity to prepare students for success in biotechnology and pharmaceutical industry positions

Whereas science college students are effectively ready for careers in biotechnology and pharmaceutical sciences when it comes to technical experience and significant considering, they not often have a chance to apply the due diligence required for fulfillment in business of their coursework. This contains framing their experience as options to challenges an organization could also be experiencing, an vital talent for the interview course of. As most lecturers haven’t utilized for positions in business, they could really feel ailing outfitted to assist college students apply the vital expertise of framing their experience inside firm objectives and to debate the enterprise and monetary ideas related to careers in scientific business.

Right here, we describe an academic exercise first developed by a pacesetter within the biotech/pharmaceutical business that was modified and given academic context by an instructional in a category of upper-level undergraduate and graduate college students. On this guided inquiry exercise, college students had been instructed to pick out a start-up firm of their field-ideally one to which they meant to use for a job. College students had been empowered by scaffolded hands-on workouts to analysis the corporate’s scientific focus and funds, and to border how their experience may assist firms obtain said objectives. College students compiled and delivered their analysis as an in-class presentation.

Readying students for careers in industry: A guided inquiry activity to prepare students for success in biotechnology and pharmaceutical industry positions

First Report of Cercospora Leaf Spot Attributable to Cercospora cf. flagellaris on Okra in China

Okra [Abelmoschus esculentus (L.) Moench], which belongs to the household Malvaceae, is extensively grown within the tropics, sub-tropics and hotter areas of the temperate zones for its immature seed pods that are consumed as a vegetable. In China, okra pods are consumed as not solely greens but additionally as a conventional medication to treatment dental ailments and gastric ulcers. Throughout September 2018 to June 2019, intensive spots on okra leaves had been noticed in a number of industrial fields (roughly 2.Zero hectares), with illness incidence of roughly 25%~50% within the Yanqing District (115°98’E, 40°46’N) of Beijing, China. Signs of the illness initially appeared as small pale brown spots with yellow haloes.
Because the illness progressed, some spots regularly coalesced, forming bigger irregular darkish brown lesions. The facilities of the lesions turned grayish white. A complete of 13 small fragments (Three to five mm) excised from the lesion margins had been sterilized in 1% sodium hypochlorite (NaClO) for 1 min, adopted by three washes with sterile distilled water, after which positioned on potato dextrose agar (PDA) and incubated at 25°C at midnight for five days. In whole, 21 cultures had been obtained and purified by single-spore subcultures on PDA for morphological identification.
The colonies on PDA had been whitish to grey, with cottony aerial mycelium. Conidiophores had been fasciculate, olivaceous brown, straight or geniculate, uniform in width, multiseptate, and ranged from 286/span> to 711 μm (avg. = 578 μm, n = 50). Conidia had been hyaline, barely curved or straight, needle formed, truncate on the base, and terminal on the tip, 3-17-septate, and measuring 52 to 231 μm (avg. = 182 μm, n = 50). The morphological options had been according to Cercospora cf. flagellaris Ellis & G. Martin (Groenewald et al. 2013).
Pathogenicity checks had been carried out on potted okra crops cv. ‘Jiayuan’. Twenty 4 wholesome okra crops on the true leaf stage had been sprayed with conidial suspensions (1 × 106 conidia/mL), incubated at a glass cupboard maintained at 25°C and 90% relative humidity (RH). To every leaf roughly 10 mL of conidial suspension was utilized. Crops sprayed with water had been used as controls. Seven days later, darkish brown spot, which had been similar to these noticed within the fields, had been noticed on inoculated leaves, whereas the management crops remained wholesome. C. cf. flagellaris was reisolated from symptomatic leaves, confirming Koch’s Postulates. Genomic DNA was extracted from fungal mycelium utilizing the Plant Genomic DNA Package (Tiangen Biotech Co. Ltd., Beijing, China).
The nuclear ribosomal inside transcribed spacer area (ITS), and parts of the actin (ACT), histone H3 (HIS3), and translation elongation issue 1-α (TEF1) genes had been amplified utilizing primers ITS1/ITS4 (Groenewald et al. 2013), ACT-512F/ACT-783R (Carbone & Kohn 1999), CYLH3F/CYLH3R (Crous et al. 2006), and EF1-728F/EF1-986R (Carbone & Kohn 1999). The ensuing 542 bp ITS, 226 bp ACT, 410 bp HIS3 and 306 bp TEF1 sequences of isolate QK14091813 had been deposited in GeneBank (Accession nos. MT949700, MT949701, MT949702 and MT949703, respectively).
The ITS, ACT, HIS3 and TEF1 sequences shared 99.42% to 100% identities to beforehand revealed sequences of C. cf. flagellaris (Accession nos. MN633275 for ITS, MF680960 for ACT, MK991295 for HIS3, and MK991292.1 for TEF1, respectively). Multi-locus phylogenetic analyses (ITS, ACT, HIS3, and TEF1) had been carried out by neighbor-joining methodology utilizing MEGA 7.0. The ensuing bushes confirmed that C. cf. flagellaris isolate QK14091813 (this examine) nested throughout the clade that features different isolates of C. cf. flagellaris with a 99% confidence stage. To our information, that is the primary report of C. cf. flagellaris inflicting leaf spot on okra (Farr and Rossman 2020). The pathogen has a worldwide distribution and an unusually broad host vary, which will be of nice significance, and the plant safety coverage of precedence to prevention and synthetical prevention ought to be adopted.

Cellufine PB

683-986-324 10 ml
EUR 452

Cellufine PB

683-986-326 50 ml Ask for price

Cellufine PB

683-986-328 500 ml Ask for price

Cellufine PB

683-986-330 5 lt Ask for price

Cellufine PB

683-986-335 10 lt Ask for price

Lead (Pb)

AT010 1mg
EUR 1368

Pseudoproto-Pb

TBW00844 unit Ask for price

MC Cellufine PB

202-15 1 x 5 ml
EUR 452

MC Cellufine PB

202-51 5 x 1 ml
EUR 452

PB Cadherin Antibody

47938-100ul 100ul
EUR 252

PB Blocking Peptide

33R-2067 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of pb antibody, catalog no. 70R-2192

PB 28 dihydrochloride

B7107-10 10 mg
EUR 284

PB 28 dihydrochloride

B7107-50 50 mg
EUR 1038

PB Cadherin Blocking Peptide

20-abx162098
  • EUR 272.00
  • EUR 411.00
  • 1 mg
  • 5 mg
  • Shipped within 5-10 working days.

PB Cadherin Conjugated Antibody

C47938 100ul
EUR 397

turboscan software densitometer

EHCA1200-SOFT ea
EUR 2744

electrolyte galv.o2/pb electr., 125ml

B151 ea
EUR 48

Pb(II) , DNA Aptamer, Biotinylated

AD-131-B Custom Ask for price

Pb(II) , DNA Aptamer, unlabeled

AD-131-U Custom Ask for price

Collagel Hydrogel Soft-Rat

CGH321 20ml
EUR 271

Collagel Hydrogel Soft+-Rat

CGH322 20ml
EUR 284

Collagel Hydrogel Soft-Bovine

CGHB321 20ml
EUR 362

Collagel Hydrogel Soft+-Bovine

CGHB322 20ml
EUR 388

Collagel Hydrogel Soft-Human

CGHH321 20ml
EUR 623

Collagel Hydrogel Soft+-Human

CGHH322 20ml
EUR 636

Pb(II) , DNA Aptamer, FITC labeled

AD-131-F Custom Ask for price

membranes+electrolyte for o2/pb electr

SZ02K ea
EUR 138

Pituitary And Brain Cadherin (PB Cadherin) Antibody

20-abx133389
  • EUR 300.00
  • EUR 439.00
  • EUR 189.00
  • 100 ul
  • 200 ul
  • 30 ul
  • Shipped within 5-10 working days.

PB-CMV-GreenPuro Scramble Hairpin Control Vector

PBSI505-000PA-1 10 ug
EUR 689
  • Category: PiggyBac Technology

flatbed scanner for ehca110-soft

EHCA1200-SCAN ea
EUR 496

3D Cell Culture Gel, soft (Col-Tgel)

P720S-10 NULL
EUR 0

3D Cell Culture Gel, soft (Col-Tgel)

P720S-2 NULL
EUR 0

Tumors of soft tissue, 102 cases (1.5mm)

SFT1021 1
EUR 250
Description: Soft tissue tumor tissue array, 102 cases of benign and malignant tumors of various soft tissues.

Tumors of soft tissue, 75 cases (1.1mm)

SFT1501 1
EUR 250
Description: Soft tissue tumor tissue array, 150 cores, 75 cases of benign and malignant tumors of various soft tissues in duplicates.

PB-CMV-MCS-EF1-Puro cDNA cloning and expression vector

PB510B-1 10 ug
EUR 702
  • Category: PiggyBac Technology

PB-CMV-MCS-EF1-GFP cDNA cloning and expression vector

PB511B-1 10 ug
EUR 702
  • Category: PiggyBac Technology

PB-CMV-MCS-EF1-RFP cDNA cloning and expression vector

PB512B-1 10 ug
EUR 702
  • Category: PiggyBac Technology

PB-CMV-MCS-EF1-GreenPuro cDNA cloning and expression vector

PB513B-1 10 ug
EUR 702
  • Category: PiggyBac Technology

PB-CMV-MCS-EF1-RedPuro cDNA Cloning and Expression Vector

PB514B-2 10 ug
EUR 702
  • Category: PiggyBac Technology

PB-EF1-MCS-IRES-GFP cDNA cloning and expression vector

PB530A-2 10 ug
EUR 702
  • Category: PiggyBac Technology

PB-EF1-MCS-IRES-RFP cDNA Cloning and Expression Vector

PB531A-2 10 ug
EUR 702
  • Category: PiggyBac Technology

PB-EF1-MCS-IRES-Neo cDNA cloning and expression vector

PB533A-2 10 ug
EUR 702
  • Category: PiggyBac Technology

PB-MSCV-MCS-EF1-GreenPuro cDNA Cloning and Expression Vector

PB713B-1 10 ug
EUR 702
  • Category: PiggyBac Technology

PB-CMV-GreenPuro-H1-MCS shRNA cloning and expression vector

PBSI505A-1 10 ug
EUR 702
  • Category: PiggyBac Technology

PB-EF1-GreenPuro-H1-MCS shRNA cloning and expression vector

PBSI506A-1 10 ug
EUR 702
  • Category: PiggyBac Technology

Human Soft Tissue Slide (Benign) (5 slides/pk)

HTS-12303 1 pk
EUR 286

Human Soft Tissue Slide (Abnormal) (5 slides/pk)

HTS-12305 1 pk
EUR 286

Alveolar Soft Part Sarcoma Chromosome Region, Candidate 1

PR27224 2 ug
EUR 191

Common diseases of soft tissue, 24 cases (2.5mm)

SFD241 1
EUR 190
Description: Soft tissue disease tissue array, 24 cases of normal, reactive and tumor conditions of various soft tissues

Common diseases of soft tissue, 24 cases (2mm)

SFD481 1
EUR 221
Description: Soft tissue disease tissue array, 24 cases of reactive and tumor conditions of various soft tissues in duplicates.

Alveolar Soft Part Sarcoma Chromosome Region, Candidate 1 Protein

20-abx263361
  • EUR 1609.00
  • EUR 328.00
  • EUR 230.00
  • 100 ug
  • 10 ug
  • 2 µg
  • Shipped within 5-10 working days.

Human Soft Tissue Slide (Adipose Undiagnosed) (5 slides/pk)

HTS-12310 1 pk
EUR 286

Human Soft Tissue Slide (Adipose Normal) (5 slides/pk)

HTS-12311 1 pk
EUR 286

Human Soft Tissue Slide (Adipose Benign) (5 slides/pk)

HTS-12313 1 pk
EUR 286

Human Soft Tissue Slide (Adipose Lipoma) (5 slides/pk)

HTS-12314 1 pk
EUR 286

Human Soft Tissue Slide (Adipose Liposarcoma) (5 slides/pk)

HTS-12316 1 pk
EUR 286

Human Soft Tissue Slide (Adipose Abnormal) (5 slides/pk)

HTS-12317 1 pk
EUR 286

3D Cell Culture Gel 2ml x(soft+medium+hard)

P720SMH-6 NULL
EUR 0

Tumors of soft tissue, 48 cases (1.5mm), set 1

SFT961 1
EUR 250
Description: Soft tissue tumor tissue array, set 1, non-overlapping with SFT962, 96 cores, 48 cases of benign and malignant tumors of various soft tissues in duplicates.

Tumors of soft tissue, 48 cases (1.5mm), set 2

SFT962 1
EUR 250
Description: Soft tissue tumor tissue array, set 2, non-overlapping with SFT961, 96 cores, 48 cases of benign and malignant tumors of various soft tissues in duplicates.

piggyBac-HR with GFP+Puro markers and TK selection [MCS1-5'PB TR-EF1?-GFP-T2A-Puro-T2A-hsvTK-pA-3' PB TR-MCS2] for Gene Correction

PBHR100A-1 10 ug
EUR 1334
  • Category: HR Donors

Human Soft Tissue Slide (Skeletal Muscle Normal) (5 slides/pk)

HTS-12341 1 pk
EUR 286

Human Soft Tissue Slide (Skeletal Muscle Benign) (5 slides/pk)

HTS-12343 1 pk
EUR 286

Human Soft Tissue Slide (Skeletal Muscle Malignant) (5 slides/pk)

HTS-12345 1 pk
EUR 286

PB-Cuo-miR-302/367-IRES-GFP-EF1-CymR-Puro Inducible iPSC Vector

PBQM-MIR302 10 ug
EUR 2022
  • Category: PiggyBac Technology

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody

BNCR2550-250 250uL
EUR 394
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), RPE conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNUB1964-100 100uL
EUR 264
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), Concentration: 0.2mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNUB1964-50 50uL
EUR 405
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), 1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNUB1964-500 500uL
EUR 513
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), Concentration: 0.2mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNUB1997-100 100uL
EUR 264
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), Concentration: 0.2mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNUB1997-50 50uL
EUR 405
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), 1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNUB1997-500 500uL
EUR 513
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), Concentration: 0.2mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody

BNUB2550-100 100uL
EUR 264
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), Concentration: 0.2mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody

BNUB2550-50 50uL
EUR 405
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), 1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody

BNUB2550-500 500uL
EUR 513
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), Concentration: 0.2mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNC551964-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF555 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNC551964-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF555 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNC551997-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF555 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNC551997-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF555 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody

BNC552550-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF555 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody

BNC552550-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF555 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNC611964-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF660R conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNC611964-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF660R conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNC611997-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF660R conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNC611997-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF660R conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody

BNC432550-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF543 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody

BNC432550-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF543 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNC471964-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF647 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNC471964-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF647 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNC471997-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF647 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNC471997-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF647 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody

BNC472550-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF647 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody

BNC472550-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF647 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNC041964-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF405S conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNC041964-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF405S conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNC041997-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF405S conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNC041997-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF405S conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody

BNC042550-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF405S conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody

BNC042550-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF405S conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNC051964-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF405M conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNC051964-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF405M conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNC051997-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF405M conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNC051997-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF405M conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody

BNC052550-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF405M conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody

BNC052550-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF405M conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNC401964-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF640R conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNC401964-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF640R conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNC401997-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF640R conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNC401997-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF640R conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody

BNC402550-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF640R conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody

BNC402550-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF640R conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNC431964-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF543 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNC431964-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF543 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNC431997-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF543 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNC431997-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF543 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNC701964-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF770 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNC701964-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF770 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNC701997-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF770 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNC701997-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF770 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody

BNC702550-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF770 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody

BNC702550-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF770 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNC801964-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF680 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNC801964-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF680 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNC801997-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF680 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNC801997-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF680 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody

BNC802550-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF680 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody

BNC802550-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF680 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNCH1964-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNCH1964-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNCH1997-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNCH1997-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody

BNCH2550-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody

BNCH2550-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNCP1964-250 250uL
EUR 394
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), PerCP conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNCP1997-250 250uL
EUR 394
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), PerCP conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody

BNCP2550-250 250uL
EUR 394
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), PerCP conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNCR1964-250 250uL
EUR 394
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), RPE conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNCR1997-250 250uL
EUR 394
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), RPE conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNC941964-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF594 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNC941964-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF594 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNC941997-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF594 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNC941997-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF594 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody

BNC942550-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF594 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody

BNC942550-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF594 conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNCA1964-250 250uL
EUR 394
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), APC conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNCA1997-250 250uL
EUR 394
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), APC conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody

BNCA2550-250 250uL
EUR 394
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), APC conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNCB1964-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), Biotin conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNCB1964-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), Biotin conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNCB1997-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), Biotin conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNCB1997-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), Biotin conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody

BNCB2550-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), Biotin conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody

BNCB2550-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), Biotin conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNC881964-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF488A conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody

BNC881964-500 500uL
EUR 545
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF488A conjugate, Concentration: 0.1mg/mL

NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody

BNC881997-100 100uL
EUR 233
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF488A conjugate, Concentration: 0.1mg/mL
Plasma and nasopharyngeal samples had been collected between 14 March and 11 April 2020 at hospital admission from 45 sufferers with RT-PCR confirmed COVID-19 and 20 adverse controls. SARS-CoV-2 antigen (Ag) was assessed in nasopharyngeal swabs utilizing the Coris Respi-Strip. For IgM/IgG detection, SureScreen Diagnostics and Szybio Biotech RDTs had been used along with laboratory assays (Abbott Alinity i SARS-CoV-2 IgG and Theradiag COVID-19 IgM ELISA).